RxDoctor Payments DataLook up a doctor →

Stephen Ramee, MD

Interventional Cardiology · New Orleans, LANPI 1780630038

Payments from drug & device makers

$1,542,681in general payments, 2019–2025

Across 367 payments — averaging $4203.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Imperative Care, Inc$1M
  • Edwards Lifesciences$426K
  • Abbott$53K
  • Boston Scientific$25K
  • Canon Medical Systems USA, Inc.$22K
  • Shockwave Medical, Inc$3K
  • plus $8K from 23 others

What the payments were for

  • Consulting fees$22,90041%
  • Speaking & faculty fees$9,20016%
  • Travel & lodging$8,95816%
  • Food & beverage$14,96227%
  • Entertainment$1090%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,542,681 in reported general payments places this provider in the 95th percentile of 171 interventional cardiology providers in Louisiana.

See all interventional cardiology providers in Louisiana

Medicare billing

Part B allowed, 2024
$38,500
Medicare patients
88
Services billed
169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate57$604
Metoprolol Succinate14$275

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →